SCHEMBL2864982

SCHEMBL2864982

CCc1c(O)cc(O)c(C(=O)c2ccc(O)cc2)c1CC(=O)N(CCO)CCOC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
SLC22A12 Q96S37 9/20 0.33
EYA3 Q99504 2/20 0.32
ESR1 P03372 2/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
ESR2 Q92731 1/20 0.32
CA14 Q9ULX7 1/20 0.32
NAMPT P43490 1/20 0.31
KDM4E B2RXH2 1/20 0.30
GLA P06280 1/20 0.30
POLB P06746 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CHRM1 P11229 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862043 0.92 SLC22A12 (0.36) SLC22A12EYA3ESR1CA12CA1
SCHEMBL2858220 0.92 TLR9 (0.36) MLYCDTLR9TLR8TLR7SLC22A12
SCHEMBL2869149 0.92 MLYCD (0.37) MLYCDTLR9TLR8TLR7NAMPT
SCHEMBL2856108 0.92 ALDH1A1 (0.35) MLYCDTLR9TLR8TLR7NAMPT
SCHEMBL2862377 0.91 ALDH1A1 (0.41) MLYCDKDM4EPOLBALDH1A1LMNA
SCHEMBL2860203 0.90 MLYCD (0.34) MLYCDTLR9TLR8TLR7TSHR
SCHEMBL2854729 0.89 MLYCD (0.40) MLYCDTLR9TLR8TLR7KDM4E
SCHEMBL2859680 0.89 MLYCD (0.33) MLYCDTLR9TLR8TLR7TSHR
SCHEMBL2865078 0.89 HSD17B1 (0.33) MLYCDTLR9TLR8TLR7KDM4E
SCHEMBL2859320 0.89 MLYCD (0.34) MLYCDTLR9TLR8TLR7CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP claimed
EP-1642880-B1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KIRIN CO LTD (JP) 2013-09-04 EP disclosed
US-7767693-B2 Hsp90 family protein inhibitors KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-08-03 US disclosed
CN-100567242-C Hsp90 family protein blockers KYOWA HAKKO KOGYO KK (JP) 2009-12-09 CN disclosed
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-10-01 US disclosed
US-7538224-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070032532-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-02-08 US disclosed
CN-1791568-A Hsp90 family protein inhibitors KYOWA HAKKO KOGYO KK (JP) 2006-06-21 CN disclosed
EP-1642880-A1 HSP90 FAMILY PROTEIN INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032532-A1 Hsp90 family protein inhibitors HSP90AB1, HSP90B1, HSP90AB2P MLYCD 3647/4885TLR9 3438/4885TLR8 1383/4885
US-20090247522-A1 Hsp90 FAMILY PROTEIN INHIBITORS HSP90AB1, HSP90B1, HSP90AB2P MLYCD 3647/4885TLR9 3438/4885TLR8 1383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.